• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, June 30, 2023


Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by Healio referenced a study published online ahead of print in the October 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net,” evaluated the effect of an intervention based on Choosing Wisely principles on prescribing antibiotics for viral respiratory tract infections in a real-world safety-net setting.

An article by HealthcareITNews referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Violence Against Healthcare Workers: A Rising Epidemic,” featured an opinion piece on how more attention needs to be given to the increasing rate of violence against workers in the health care industry.

An article from Dermatology Times® referenced an article published on AJMC.com. The article, “Experts Herald ‘Year of the JAK Inhibitor’ in Dermatology,” covered a panel at the American Academy of Dermatology 2023 that featured speakers discussing current data on the use of Janus kinase (JAK) inhibitors in dermatology.

An article from The Western Journal referenced an article published on AJMC.com. The article, “NATALEE: Ribociclib With Hormonal Therapy Cuts Recurrence Risk by 25% in Most Common Type of Breast Cancer,” focused on a trial that included patients with earlier stage breast cancer normally considered lower risk.

Related Videos
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Video 1 - "Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers"
Landman family
Related Content
© 2023 MJH Life Sciences
All rights reserved.